Novo Nordisk Aktie
| 42,07EUR | -0,58EUR | -1,35% |
WKN DE: A3EU6F / ISIN: DK0062498333
Diese Analysten bewerten die Novo Nordisk-Aktie
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| Jefferies & Company Inc. | 270,00DKK | -14,83% | 07:01 | |||
| Barclays Capital | 375,00DKK | 18,30% | 28.11.25 | |||
| Deutsche Bank AG | 475,00DKK | 49,84% | 27.11.25 | |||
| Goldman Sachs Group Inc. | 353,00DKK | 11,36% | 26.11.25 | |||
| JP Morgan Chase & Co. | 500,00DKK | 57,73% | 25.11.25 | |||
| UBS AG | 315,00DKK | -0,63% | 18.11.25 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 400,00DKK | 26,18% | 14.11.25 | |||
| Bernstein Research | 540,00DKK | 70,35% | 07.11.25 |
Historische Rating-Entwicklung
|
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|